Cone-Rod Dystrophy

Wednesday, November 29 2023 | 08 h 21 min | Vision Science

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa. Beacon will undertake preclinical work on a potential gene therapy for cone-rod dystrophy caused by mutations in the CDHR1 gene.

This work was originally started by Dr. Robert MacLaren (University of Oxford) who is a co-founder and adviser to the company. If these studies are successful, Beacon hopes to move the CDHR1 gene therapy to a human clinical trial in the coming years.

Featured Posts

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Learn More

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the University of Waterloo have entered into a strategic partnership to advance vision science research and therapeutic development, as well as to enhance eye care delivery on a global scale.

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

IRIS Wins 2024 Mercuriades Award

Learn More

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Clinical Trial Results for New Treatments for AMD and DME

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

IRIS Wins 2024 Mercuriades Award

Learn More

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Clinical Trial Results for New Treatments for AMD and DME

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

IRIS Wins 2024 Mercuriades Award

Learn More

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Clinical Trial Results for New Treatments for AMD and DME

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.